Loading...
XSHG603077
Market cap2.23bUSD
Jan 16, Last price  
1.96CNY
1D
0.51%
1Q
-0.51%
Jan 2017
-15.78%
IPO
62.21%
Name

Sichuan Hebang Biotechnology Co Ltd

Chart & Performance

D1W1MN
XSHG:603077 chart
P/E
12.76
P/S
1.85
EPS
0.15
Div Yield, %
2.40%
Shrs. gr., 5y
-0.83%
Rev. gr., 5y
7.99%
Revenues
8.82b
-32.33%
844,372,6841,432,872,1501,899,970,0791,737,770,8891,602,663,9642,185,698,5722,862,644,1293,462,551,5454,737,645,9676,009,019,0925,969,100,7075,260,765,9889,867,109,12413,038,947,9868,824,107,811
Net income
1.28b
-66.29%
44,156,190172,798,343366,276,401334,893,72364,437,347671,762,995239,865,850317,810,832517,539,883363,087,307516,853,7612,909,5423,018,470,6123,806,808,8691,283,243,893
CFO
201m
-92.41%
68,967,587330,766,072552,563,091134,959,7610204,674,407449,197,351575,257,187176,944,298944,392,173162,920,484368,854,1553,196,718,0232,644,262,791200,759,143
Dividend
Jun 07, 20230.045 CNY/sh
Earnings
May 15, 2025

Profile

Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. Sichuan Hebang Biotechnology Corporation Limited was founded in 2002 and is based in Chengdu, China.
URL
https://www.hebang.cn/
IPO date
Jul 31, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,824,108
-32.33%
13,038,948
32.15%
Cost of revenue
6,993,670
7,645,257
Unusual Expense (Income)
NOPBT
1,830,438
5,393,691
NOPBT Margin
20.74%
41.37%
Operating Taxes
257,266
668,323
Tax Rate
14.05%
12.39%
NOPAT
1,573,171
4,725,367
Net income
1,283,244
-66.29%
3,806,809
26.12%
Dividends
(392,632)
(130,877)
Dividend yield
1.91%
0.50%
Proceeds from repurchase of equity
(500,370)
668,693
BB yield
2.44%
-2.53%
Debt
Debt current
1,167,635
1,389,687
Long-term debt
480,554
451,567
Deferred revenue
79,030
Other long-term liabilities
75,749
1
Net debt
(2,083,209)
(3,427,423)
Cash flow
Cash from operating activities
200,759
2,644,263
CAPEX
(828,735)
Cash from investing activities
(902,654)
Cash from financing activities
(943,597)
1,004,984
FCF
(309,711)
1,774,557
Balance
Cash
3,064,128
4,591,309
Long term investments
667,270
677,368
Excess cash
3,290,192
4,616,729
Stockholders' equity
19,045,328
19,582,528
Invested Capital
18,627,183
16,907,199
ROIC
8.85%
30.65%
ROCE
8.31%
24.95%
EV
Common stock shares outstanding
8,705,861
8,697,302
Price
2.36
-22.37%
3.04
-10.85%
Market cap
20,545,832
-22.29%
26,439,797
-8.09%
EV
19,105,663
23,657,236
EBITDA
2,832,912
6,323,288
EV/EBITDA
6.74
3.74
Interest
24,373
51,435
Interest/NOPBT
1.33%
0.95%